[{"id":"49b9330a-3c6f-4221-be3c-8abb5d657c10","acronym":"","url":"https://clinicaltrials.gov/study/NCT02952729","created_at":"2021-01-18T14:30:06.237Z","updated_at":"2024-07-02T16:36:34.109Z","phase":"Phase 1b","brief_title":"Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2","source_id_and_acronym":"NCT02952729","lead_sponsor":"Mersana Therapeutics","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 amplification","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e XMT-1522"],"overall_status":"Completed","enrollment":" Enrollment 120","initiation":"Initiation: 11/21/2016","start_date":" 11/21/2016","primary_txt":" Primary completion: 01/28/2019","primary_completion_date":" 01/28/2019","study_txt":" Completion: 01/28/2019","study_completion_date":" 01/28/2019","last_update_posted":"2021-02-24"}]